829 related articles for article (PubMed ID: 20061621)
1. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
Matsuda N; Tanaka K
J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
[TBL] [Abstract][Full Text] [Related]
2. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
Ross CA; Pickart CM
Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
[TBL] [Abstract][Full Text] [Related]
3. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease.
Pan T; Kondo S; Le W; Jankovic J
Brain; 2008 Aug; 131(Pt 8):1969-78. PubMed ID: 18187492
[TBL] [Abstract][Full Text] [Related]
4. The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B+1.
Hol EM; van Leeuwen FW; Fischer DF
Trends Mol Med; 2005 Nov; 11(11):488-95. PubMed ID: 16213790
[TBL] [Abstract][Full Text] [Related]
5. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-proteasome system dysfunction in Parkinson's disease: current evidence and controversies.
Lim KL
Expert Rev Proteomics; 2007 Dec; 4(6):769-81. PubMed ID: 18067415
[TBL] [Abstract][Full Text] [Related]
7. Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches.
Paul S
Bioessays; 2008 Nov; 30(11-12):1172-84. PubMed ID: 18937370
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-proteasome system and Parkinson's disease.
Olanow CW; McNaught KS
Mov Disord; 2006 Nov; 21(11):1806-23. PubMed ID: 16972273
[TBL] [Abstract][Full Text] [Related]
9. Formation of distinct inclusion bodies by inhibition of ubiquitin-proteasome and autophagy-lysosome pathways.
Lee J; Yang KH; Joe CO; Kang SS
Biochem Biophys Res Commun; 2011 Jan; 404(2):672-7. PubMed ID: 21147067
[TBL] [Abstract][Full Text] [Related]
10. The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim?
Dennissen FJ; Kholod N; van Leeuwen FW
Prog Neurobiol; 2012 Feb; 96(2):190-207. PubMed ID: 22270043
[TBL] [Abstract][Full Text] [Related]
11. Global changes to the ubiquitin system in Huntington's disease.
Bennett EJ; Shaler TA; Woodman B; Ryu KY; Zaitseva TS; Becker CH; Bates GP; Schulman H; Kopito RR
Nature; 2007 Aug; 448(7154):704-8. PubMed ID: 17687326
[TBL] [Abstract][Full Text] [Related]
12. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
Gallardo G; Schlüter OM; Südhof TC
Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
Hol EM; Fischer DF; Ovaa H; Scheper W
Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
[TBL] [Abstract][Full Text] [Related]
14. The neuronal ubiquitin-proteasome system: murine models and their neurological phenotype.
van Tijn P; Hol EM; van Leeuwen FW; Fischer DF
Prog Neurobiol; 2008 Jun; 85(2):176-93. PubMed ID: 18448229
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease.
Hatano T; Kubo S; Sato S; Hattori N
J Neurochem; 2009 Dec; 111(5):1075-93. PubMed ID: 19780902
[TBL] [Abstract][Full Text] [Related]
16. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.
Sun F; Kanthasamy A; Anantharam V; Kanthasamy AG
Pharmacol Ther; 2007 Jun; 114(3):327-44. PubMed ID: 17521740
[TBL] [Abstract][Full Text] [Related]
17. Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease.
McNaught KS; Olanow CW
Neurobiol Aging; 2006 Apr; 27(4):530-45. PubMed ID: 16207501
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.
Mandel S; Grunblatt E; Riederer P; Amariglio N; Jacob-Hirsch J; Rechavi G; Youdim MB
Ann N Y Acad Sci; 2005 Aug; 1053():356-75. PubMed ID: 16179542
[TBL] [Abstract][Full Text] [Related]
19. Protein degradation, aggregation, and misfolding.
Cuervo AM; Wong ES; Martinez-Vicente M
Mov Disord; 2010; 25 Suppl 1():S49-54. PubMed ID: 20187257
[TBL] [Abstract][Full Text] [Related]
20. Does smoking reduce the risk of Parkinson's disease through stimulation of the ubiquitin-proteasome system?
Chapman MA
Med Hypotheses; 2009 Dec; 73(6):887-91. PubMed ID: 19540050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
